Photobiomodulation Therapy Plus M-health in Head and Neck Cancer Patients: LAXER Study
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversidad de Granada
About this trial
The Photobiomodulation therapy could have positive effects on quality of life and oral health in head and neck cancer survivors post-radiotherapy. The improvement in quality of life will be maintained after a follow-up period.
Eligibility criteria
Qualifiers
men or women aged 18 years or older and were diagnosed with HNC.
chronic xerostomia.
received RT in the parotid, submandibular and/or sublingual salivary glands.
grade 3 oral dryness according to the Common Terminology Criteria for Adverse Events version 5.0 (CTCAE).
Disqualifiers
patients with metastases.
a score <60 on the Karnofsky Performance Status Scale.
contraindications to receiving PBM therapy (e.g., cardiac arrhythmias, pacemakers, photosensitivity, drugs with photosensitizing action, and pregnancy).
other comorbidities such as diabetes and polypharmacy.
Trial design
Treatments tested in this trial
- Energy density photobiomodulation (7.5)
- Energy density photobiomodulation (3)
- Sham placebo
Treatment groups
60 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov